Cartesian Therapeutics
RNAC
#8958
Rank
S$0.24 B
Marketcap
S$7.92
Share price
4.24%
Change (1 day)
-16.23%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2026 (TTM): -S$67.88 Million

According to Cartesian Therapeutics's latest financial reports the company's current earnings are S$1.47 Million. In 2025 the company made an earning of -S$63.23 Million a decrease over its 2024 earnings that were of -S$35.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$67.88 Million7.36%
2025 -S$63.23 Million80.63%
2024 -S$35.01 Million-88.5%
2023 -S$0.31 Billion-724%
2022 S$48.76 M-649.67%
2021 -S$8.88 Million-89.78%
2020 -S$86.85 Million25.06%
2019 -S$69.45 Million-15.68%
2018 -S$82.36 Million-0.43%
2017 -S$82.71 Million83.41%
2016 -S$45.1 Million44.3%
2015 -S$31.26 Million